CLGN · CollPlant Biotechnologies Ltd
$0.31
-0.02 (-4.82%)
At close · Jul 29
Market Cap
$5.90M
Shares
18.91M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.37M
+360.4%
FY2025
Net Income
-$11.49M
+30.8%
FY2025
Gross Margin
64.78%
+280.3pp
FY2025
Operating Margin
-484.31%
+2865.4pp
FY2025
Diluted EPS
-$0.94
+35.2%
FY2025
Operating Cash Flow
-$9.42M
+33.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $2.37M | $515K | $10.96M | $299K | $15.64M | $6.14M | — | |
| $835K | $1.63M | $1.99M | $400K | $2.01M | $3M | — | |
| $1.54M | -$1.11M | $8.97M | -$101K | $13.64M | $3.14M | — | |
| 64.78% | -215.53% | 81.83% | -33.78% | 87.18% | 51.08% | — | |
| $8.19M | $10.52M | $10.48M | $10.26M | $7.63M | $4.07M | $28K | |
| $4.83M | $5.63M | $6M | $6.74M | $5.94M | $4.67M | — | |
| $912K | $1.04M | $1.1M | — | — | $660K | — | |
| — | — | — | — | — | $34K | — | |
| -$11.48M | -$17.25M | -$7.51M | -$17.1M | $65K | -$5.6M | — | |
| -484.31% | -3349.71% | -68.55% | -5718.06% | 0.42% | -91.23% | — | |
| -$10.57M | -$16.21M | -$6.41M | — | — | -$4.94M | — | |
| $380K | $738K | $788K | — | — | — | — | |
| -$6000 | $642K | $493K | $172K | $172K | — | — | |
| — | $45.99M | $59.99M | — | — | — | — | |
| -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237K | -$5.77M | — | |
| -484.56% | -3225.05% | -64.05% | -5660.54% | 1.52% | -94.09% | — | |
| — | — | — | — | — | -$5.77M | — | |
| USD/shares | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | — | — |
| USD/shares | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | — | — |
| shares | 12.2M | 11.45M | 11.39M | 11.03M | 9.97M | 6.89M | — |
| shares | 12.2M | 11.45M | 11.39M | 11.03M | 11.97M | 6.89M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| United States | $2,176,000 | $484,000 | $10,839,000 | $16,000 | $14,951,000 | $5,768,000 | $2,078,000 |
| Europe and Other | $98,000 | — | $28,000 | $104,000 | $633,000 | — | — |
| Canada | $96,000 | — | $87,000 | $158,000 | $57,000 | — | — |
| Israel | $1,000 | $31,000 | $5,000 | $21,000 | — | — | — |
| Europe | — | — | — | — | — | $369,000 | $240,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues from Milestones | $2,000,000 | — | $10,000,000 | — | — |
| Revenues from Sales of Goods | $371,000 | $515,000 | $959,000 | $299,000 | $1,595,000 |
| Revenues From Licensing Agreement | — | — | — | — | $14,000,000 |
| Revenues From Rendering Of Services | — | — | — | — | $46,000 |